Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 218

1.

Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.

Takahashi Y, Iwamoto T, Suzuki Y, Kajiwara Y, Hatono M, Tsukioki T, Kawada K, Kochi M, Ikeda H, Shien T, Taira N, Matsuoka J, Doihara H, Toyooka S.

Clin Breast Cancer. 2019 Sep 9. pii: S1526-8209(19)30643-3. doi: 10.1016/j.clbc.2019.07.001. [Epub ahead of print]

PMID:
31570267
2.

Case report of hepatic pseudocyst: A rare manifestation of liver metastasis from an anal squamous cell carcinoma.

Bekki T, Takakura Y, Kochi M, Kushitani K, Mori K, Arihiro K, Teraoka Y, Egi H, Ohdan H.

Int J Surg Case Rep. 2019;62:77-84. doi: 10.1016/j.ijscr.2019.08.005. Epub 2019 Aug 17.

3.

Perioperative management of a bleeding jejunal tumor in a patient with erythropoietic protoporphyria: A case report and literature review.

Takemoto Y, Mukai S, Mochizuki T, Kochi M, Egi H, Ohdan H.

Int J Surg Case Rep. 2019;60:191-195. doi: 10.1016/j.ijscr.2019.03.048. Epub 2019 Apr 5.

4.

Synbiotics suppress colitis-induced tumorigenesis in a colon-specific cancer mouse model.

Saito Y, Hinoi T, Adachi T, Miguchi M, Niitsu H, Kochi M, Sada H, Sotomaru Y, Sakamoto N, Sentani K, Oue N, Yasui W, Tashiro H, Ohdan H.

PLoS One. 2019 Jun 26;14(6):e0216393. doi: 10.1371/journal.pone.0216393. eCollection 2019.

5.

Is laparoscopic colorectal surgery with continuation of antiplatelet therapy safe without increasing bleeding complications?

Taguchi K, Shimomura M, Egi H, Hattori M, Mukai S, Kochi M, Sada H, Sumi Y, Nakashima I, Akabane S, Sato K, Ohdan H.

Surg Today. 2019 Jun 22. doi: 10.1007/s00595-019-01839-0. [Epub ahead of print]

PMID:
31230127
6.

[A Case of Advanced Gastric Cancer with Bone Marrow Metastasis Treated with Low-Dose Combination Chemotherapy Containing S-1 and Docetaxel].

Watabe M, Kochi M, Nishimaki H, Kano H, Tamegai H, Shimizu H, Matsuno Y, Kawai T, Masuda S, Sugitani M, Fujii M, Takayama T.

Gan To Kagaku Ryoho. 2019 May;46(5):933-936. Japanese.

PMID:
31189819
7.

Successful Resection of Solitary Abdominal Wall Metastasis of Sarcomatous Intrahepatic Cholangiocarcinoma.

Ono K, Hamaoka M, Egi H, Kobayashi T, Tahara H, Kuroda S, Shimizu S, Mukai S, Kochi M, Shiroma N, Arihiro K, Ohdan H.

Case Rep Gastroenterol. 2019 Feb 14;13(1):66-72. doi: 10.1159/000496917. eCollection 2019 Jan-Apr.

8.

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.

Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M.

J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29.

PMID:
30925125
9.

Amplified Association Between Blood Pressure and Albuminuria in Overweight Patients With Biopsy-Proven Hypertensive Nephrosclerosis.

Kohagura K, Furuichi K, Kochi M, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T; Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.

Am J Hypertens. 2019 Apr 22;32(5):486-491. doi: 10.1093/ajh/hpz010.

PMID:
30689693
10.

Surgical techniques for advanced transverse colon cancer using the pincer approach of the transverse mesocolon.

Egi H, Nakashima I, Hattori M, Mukai S, Kochi M, Taguchi K, Sada H, Sumi Y, Ohdan H.

Surg Endosc. 2019 Feb;33(2):639-643. doi: 10.1007/s00464-018-6491-7. Epub 2018 Oct 23.

PMID:
30353241
11.

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer.

Sunakawa Y, Mogushi K, Lenz HJ, Zhang W, Tsuji A, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Tanioka H, Negoro Y, Moran M, Astrow SH, Hsiang J, Stephens C, Fujii M, Ichikawa W.

Mol Cancer Ther. 2018 Dec;17(12):2788-2795. doi: 10.1158/1535-7163.MCT-18-0694. Epub 2018 Oct 1.

PMID:
30275242
12.

A case of ascending colon cancer accompanied with tumor thrombosis in the superior mesenteric vein treated with right hemicolectomy and greater saphenous vein grafting.

Akabane S, Mukai S, Egi H, Adachi T, Kochi M, Sato K, Sumi Y, Nakashima I, Taguchi K, Sada H, Ishikawa A, Yasui W, Ohdan H.

Int J Surg Case Rep. 2018;51:358-363. doi: 10.1016/j.ijscr.2018.09.007. Epub 2018 Sep 9.

13.

Laparoscopic management of refractory chylous ascites using fluorescence navigation with indocyanine green: A case report.

Shimajiri H, Egi H, Yamamoto M, Kochi M, Mukai S, Ohdan H.

Int J Surg Case Rep. 2018;49:149-152. doi: 10.1016/j.ijscr.2018.06.008. Epub 2018 Jun 23.

14.

Left colic artery-preserving D3 lymphadenectomy using near-infrared spectroscopy was effective for double advanced cancers of the transverse colon and rectum: A case report.

Yamamoto M, Egi H, Kochi M, Mukai S, Ohdan H.

Int J Surg Case Rep. 2018;49:131-135. doi: 10.1016/j.ijscr.2018.06.029. Epub 2018 Jun 28.

15.

Hyponatremia and mortality among very elderly residents in a geriatric health service facility.

Naka T, Kohagura K, Kochi M, Ohya Y.

Clin Exp Nephrol. 2018 Dec;22(6):1404-1410. doi: 10.1007/s10157-018-1607-x. Epub 2018 Jun 27.

PMID:
29951722
16.

Current Multidisciplinary Approach to Fertility Preservation for Breast Cancer Patients.

Takahashi Y, Shien T, Sakamoto A, Tsuyumu Y, Yoshioka R, Uno M, Hatono M, Kochi M, Kawada K, Tsukioki T, Iwamoto T, Ikeda H, Taira N, Matsuoka J, Nakatsuka M, Doihara H.

Acta Med Okayama. 2018 Apr;72(2):137-142. doi: 10.18926/AMO/55854.

17.

Risk factors for postoperative pneumonia in elderly patients with colorectal cancer: a sub-analysis of a large, multicenter, case-control study in Japan.

Kochi M, Hinoi T, Niitsu H, Ohdan H, Konishi F, Kinugasa Y, Kobatake T, Ito M, Inomata M, Yatsuoka T, Ueki T, Tashiro J, Yamaguchi S, Watanabe M; Japan Society of Laparoscopic Colorectal Surgery.

Surg Today. 2018 Aug;48(8):756-764. doi: 10.1007/s00595-018-1653-8. Epub 2018 Mar 29.

PMID:
29594413
18.

CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer.

Sunakawa Y, Tsuji A, Denda T, Segawa Y, Negoro Y, Shimada K, Kochi M, Nakamura M, Kotaka M, Tanioka H, Takagane A, Tani S, Yamaguchi T, Watanabe T, Takeuchi M, Fujii M, Ichikawa W.

Target Oncol. 2017 Dec;12(6):787-794. doi: 10.1007/s11523-017-0527-0.

PMID:
29064002
19.

Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis.

Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y.

J Cardiol. 2018 Mar;71(3):277-283. doi: 10.1016/j.jjcc.2017.08.008. Epub 2017 Sep 30.

20.

Augmented Association Between Blood Pressure and Proteinuria in Hyperuricemic Patients With Nonnephrotic Chronic Kidney Disease.

Kohagura K, Kochi M, Miyagi T, Zamami R, Nagahama K, Yonemoto K, Ohya Y.

Am J Hypertens. 2018 Mar 10;31(4):480-485. doi: 10.1093/ajh/hpx166.

PMID:
28927237
21.

Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.

Kochi M, Iwamoto T, Niikura N, Bianchini G, Masuda S, Mizoo T, Nogami T, Shien T, Motoki T, Taira N, Tokuda Y, Doihara H, Matsuoka J, Fujiwara T.

Breast Cancer Res Treat. 2018 Jan;167(1):39-47. doi: 10.1007/s10549-017-4502-3. Epub 2017 Sep 13.

PMID:
28905250
22.

Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy.

Okada S, Yamazaki S, Kaiga T, Funada T, Kochi M, Takayama T.

World J Surg Oncol. 2017 Aug 24;15(1):162. doi: 10.1186/s12957-017-1226-0.

23.

Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma.

Kawai T, Kochi M, Fujii M, Song K, Hagiwara K, Watanabe M, Matsuno Y, Suda H, Yagi R, Takayama T.

Anticancer Res. 2017 Jun;37(6):3301-3306.

PMID:
28551681
24.

Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers.

Iwamoto T, Katagiri T, Niikura N, Miyoshi Y, Kochi M, Nogami T, Shien T, Motoki T, Taira N, Omori M, Tokuda Y, Fujiwara T, Doihara H, Gyorffy B, Matsuoka J.

Oncotarget. 2017 Apr 18;8(16):26122-26128. doi: 10.18632/oncotarget.15385.

25.

possible role of soluble fibrin monomer complex after gastroenterological surgery.

Kochi M, Shimomura M, Hinoi T, Egi H, Tanabe K, Ishizaki Y, Adachi T, Tashiro H, Ohdan H.

World J Gastroenterol. 2017 Mar 28;23(12):2209-2216. doi: 10.3748/wjg.v23.i12.2209.

26.

[Preoperative Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma].

Kawai T, Kochi M, Fujii M, Song K, Hagiwara K, Tamegai H, Watanabe M, Matsuno Y, Takayama Y, Suda H, Takayama T.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1427-1429. Japanese.

PMID:
28133012
27.

Clinical Significance of Pharmacological Prophylaxis based on the Original Risk Classification of Venous Thromboembolism after Lower Abdominal Surgery.

Shimomura M, Kochi M, Hinoi T, Egi H, Adachi T, Kobayashi T, Tashiro H, Ohdan H.

Hiroshima J Med Sci. 2016 Dec;65(3-4):53-59.

PMID:
29989720
28.

Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials.

Sunakawa Y, Ichikawa W, Tsuji A, Denda T, Segawa Y, Negoro Y, Shimada K, Kochi M, Nakamura M, Kotaka M, Tanioka H, Takagane A, Tani S, Yamaguchi T, Watanabe T, Takeuchi M, Fujii M, Nakajima T.

Clin Colorectal Cancer. 2017 Sep;16(3):e171-e180. doi: 10.1016/j.clcc.2016.09.010. Epub 2016 Oct 6.

PMID:
27856123
29.

Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.

Miguchi M, Hinoi T, Shimomura M, Adachi T, Saito Y, Niitsu H, Kochi M, Sada H, Sotomaru Y, Ikenoue T, Shigeyasu K, Tanakaya K, Kitadai Y, Sentani K, Oue N, Yasui W, Ohdan H.

PLoS One. 2016 Nov 11;11(11):e0166422. doi: 10.1371/journal.pone.0166422. eCollection 2016.

30.

Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis.

Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y.

PLoS One. 2016 Aug 18;11(8):e0160225. doi: 10.1371/journal.pone.0160225. eCollection 2016.

31.

KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer.

Niitsu H, Hinoi T, Kawaguchi Y, Sentani K, Yuge R, Kitadai Y, Sotomaru Y, Adachi T, Saito Y, Miguchi M, Kochi M, Sada H, Shimomura M, Oue N, Yasui W, Ohdan H.

Oncogenesis. 2016 Aug 15;5(8):e253. doi: 10.1038/oncsis.2016.47.

32.

Increased Calcineurin A Expression Is Associated with a Lower Relapse-Free Survival Rate after Colorectal Cancer Surgery.

Niitsu H, Hinoi T, Sentani K, Mukai S, Adachi T, Saito Y, Miguchi M, Kochi M, Sada H, Oue N, Yasui W, Ohdan H.

Pathobiology. 2016;83(6):308-15. doi: 10.1159/000445121. Epub 2016 Jun 21.

33.

Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05).

Tsuji A, Sunakawa Y, Ichikawa W, Nakamura M, Kochi M, Denda T, Yamaguchi T, Shimada K, Takagane A, Tani S, Kotaka M, Kuramochi H, Furushima K, Koike J, Yonemura Y, Takeuchi M, Fujii M, Nakajima T.

Target Oncol. 2016 Dec;11(6):799-806.

PMID:
27306648
34.

Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer.

Sunakawa Y, Yang D, Moran M, Astrow SH, Tsuji A, Stephens C, Zhang W, Cao S, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Masuishi T, Takeuchi M, Fujii M, Nakajima T, Ichikawa W, Lenz HJ.

Cancer Biol Ther. 2016 Jul 2;17(7):751-9. doi: 10.1080/15384047.2016.1178426. Epub 2016 Apr 22.

35.

Total colectomy for multiple metachronous colon cancers in a patient with Lynch syndrome.

Kochi M, Shimomura M, Hinoi T, Niitsu H, Yano T, Mukai S, Sawada H, Miguchi M, Saito Y, Adachi T, Ishizaki Y, Egi H, Ohdan H.

Surg Case Rep. 2015 Sep 9;1(1):78. doi: 10.1186/s40792-015-0081-x. eCollection 2015 Dec.

36.

Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05).

Tanabe K, Fujii M, Nishikawa K, Kunisaki C, Tsuji A, Matsuhashi N, Takagane A, Ohno T, Kawase T, Kochi M, Yoshida K, Kakeji Y, Ichikawa W, Chin K, Terashima M, Takeuchi M, Nakajima T; JACCRO GC-05 study group.

Ann Oncol. 2015 Sep;26(9):1916-22. doi: 10.1093/annonc/mdv265. Epub 2015 Jun 24.

PMID:
26109630
37.

Effect of preoperative colonic drainage for obstructing colorectal cancer.

Kochi M, Fujii M, Hagiwara K, Tamegai H, Watanabe M, Matsuno Y, Takayama Y, Suda H, Takayama T.

Int Surg. 2015 May;100(5):790-6. doi: 10.9738/INTSURG-D-14-00262.1.

38.

Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.

Niitsu H, Hinoi T, Shimomura M, Egi H, Hattori M, Ishizaki Y, Adachi T, Saito Y, Miguchi M, Sawada H, Kochi M, Mukai S, Ohdan H.

World J Surg Oncol. 2015 Apr 24;13:162. doi: 10.1186/s12957-015-0570-1.

39.

Complete response to uracil-tegafur alone in advanced rectal cancer.

Suda H, Kochi M, Fujii M, Kanamori N, Mihara Y, Tamegai H, Funada T, Watanabe M, Takayama T.

Hepatogastroenterology. 2014 Nov-Dec;61(136):2212-4.

PMID:
25699353
40.

Resection of Colorectal Cancer With Versus Without Preservation of Inferior Mesenteric Artery.

Mihara Y, Kochi M, Fujii M, Kanamori N, Funada T, Teshima Y, Jinno D, Takayama T.

Am J Clin Oncol. 2017 Aug;40(4):381-385. doi: 10.1097/COC.0000000000000170.

PMID:
25503427
41.

Successful management of the cervicothoracic esophagus reconstruction by expanded skin flap.

Kashimura T, Nakazawa H, Shimoda K, Soejima K, Kochi M, Takayama T.

Ann Thorac Surg. 2014 Dec;98(6):2211-3. doi: 10.1016/j.athoracsur.2014.01.073. Epub 2014 Dec 1.

PMID:
25468093
42.

Radiochemotherapy for esophageal squamous cell carcinoma in elderly patients.

Hagiwara K, Kochi M, Fujii M, Song K, Tamegai H, Watanabe M, Takayama Y, Suda H, Teshima Y, Takayama T.

Hepatogastroenterology. 2014 Sep;61(134):1617-22.

PMID:
25436352
43.

Phase II Study of Neoadjuvant Chemotherapy With S-1 and CDDP in Patients With Lymph Node Metastatic Stage II or III Gastric Cancer.

Kochi M, Fujii M, Kanamori N, Mihara Y, Funada T, Tamegai H, Watanabe M, Takayama Y, Suda H, Takayama T.

Am J Clin Oncol. 2017 Feb;40(1):17-21. doi: 10.1097/COC.0000000000000058.

PMID:
24662266
44.

Interrelationship between brachial artery function and renal small artery sclerosis in chronic kidney disease.

Miyagi T, Kohagura K, Ishiki T, Kochi M, Kinjyo T, Kinjyo K, Maehara Y, Sakima A, Iseki K, Ohya Y.

Hypertens Res. 2014 Sep;37(9):863-9. doi: 10.1038/hr.2014.60. Epub 2014 Mar 20.

PMID:
24646648
45.

Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes.

Kochi M, Fujii M, Masuda S, Kanamori N, Mihara Y, Funada T, Tamegai H, Watanabe M, Suda H, Takayama T.

Diagn Pathol. 2013 Nov 21;8:191. doi: 10.1186/1746-1596-8-191.

46.

FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study.

Kochi M, Akiyama Y, Aoki T, Hagiwara K, Takahashi T, Hironaka K, Teranishi F, Osuka F, Takeuchi M, Fujii M, Nakajima T.

Cancer Chemother Pharmacol. 2013 Nov;72(5):1097-102. doi: 10.1007/s00280-013-2292-9. Epub 2013 Sep 22.

PMID:
24057041
47.

Hypertriglyceridemia accompanied by increased serum complement component 3 and proteinuria in non-nephrotic chronic kidney disease.

Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Kinjyo K, Nagahama K, Sakima A, Iseki K, Ohya Y.

Clin Exp Nephrol. 2014 Jun;18(3):453-60. doi: 10.1007/s10157-013-0825-5. Epub 2013 Jun 12.

PMID:
23757050
48.

Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites.

Tamegai H, Kaiga T, Kochi M, Fujii M, Kanamori N, Mihara Y, Funada T, Shimizu H, Jinno D, Takayama T.

Cancer Chemother Pharmacol. 2013 Mar;71(3):727-31. doi: 10.1007/s00280-012-2066-9. Epub 2013 Jan 12.

PMID:
23314679
49.

Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).

Shibui S, Narita Y, Mizusawa J, Beppu T, Ogasawara K, Sawamura Y, Kobayashi H, Nishikawa R, Mishima K, Muragaki Y, Maruyama T, Kuratsu J, Nakamura H, Kochi M, Minamida Y, Yamaki T, Kumabe T, Tominaga T, Kayama T, Sakurada K, Nagane M, Kobayashi K, Nakamura H, Ito T, Yazaki T, Sasaki H, Tanaka K, Takahashi H, Asai A, Todo T, Wakabayashi T, Takahashi J, Takano S, Fujimaki T, Sumi M, Miyakita Y, Nakazato Y, Sato A, Fukuda H, Nomura K.

Cancer Chemother Pharmacol. 2013 Feb;71(2):511-21. doi: 10.1007/s00280-012-2041-5. Epub 2012 Dec 11.

PMID:
23228988
50.

An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study.

Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Nagahama K, Sakima A, Iseki K, Ohya Y.

Hypertens Res. 2013 Jan;36(1):43-9. doi: 10.1038/hr.2012.135. Epub 2012 Sep 6.

PMID:
22951520

Supplemental Content

Support Center